April 2022 ARS Meeting

MEETING NOTICE AND AGENDA

REGULAR MEETING OF
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: April 19, 2022
Time: 9:00 am to 11:00 am

Location: 685 Gateway Blvd., Conf. Rm. B
South San Francisco, CA 94080

 

Due to the expiration of Executive Order N-1-22, which extended the suspension of certain provisions of the Bagley-Keene Open Meeting Act until March 31, 2022 in response to the COVID-19 pandemic, this meeting of the Application Review Subcommittee will be conducted in person and via noticed teleconference locations, which will be made accessible to the public.  Members of the public may attend this meeting in person at the address printed above, at a teleconference location listed below, or remotely via the options listed below.

Teleconference Locations

  • 327 McCartney Ct,  Lincoln, CA 95648
  • 10996 Torreyana Road, Suite 200, San Diego, CA 92121
  • 183 St. Thomas Way. Tiburon, CA 94920
  • 6220 Playa Vista Place, Avila Beach, CA 93424
  • 810 El Chorro Way, Sacramento, CA 95864
  • 10850 Gold Center Drive, Suite 325, Rancho Cordova, CA  95670
  • 2007 Redwood Rd., Napa, CA 94558
  • 44 Dorothy Way, Novato, CA 94945
  • 21211 Rainbow Drive, Cupertino, CA 95014
  • 10290 Campus Point Drive, San Diego, CA 92121
  • 5950 Canoga Ave, Suite 110, Woodland Hills, CA 91367
  • 278 N 7th St, San Jose, CA 95112
  • 1108 Myrtle Street Calistoga, CA 94515
  • 216 South Westgate Ave, Los Angeles, CA 90049
  • 2619 Montclair Street. San Diego, CA 92104
  • 4005 N Fresno St. Suite 104, Fresno, CA 94736
  • 9301 Wilshire Blvd., Beverly Hills, CA 90210
  • 2 Koret Way, San Francisco, CA 94143

 

Public Comment Instructions

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following:  

  • Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment
  • Once we call your name you will have 3 Minutes to make your public comment; please remember to be respectful of the time limit.
  • Written comment may be sent to the following email address: kmccormack@cirm.ca.gov
  • Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location.
     

YouTube: www.youtube.com/cirmtv

Dial-In information:

Dial in number: (669) 900-6833

Meeting ID: 857 4194 0861

Passcode: 220419
 

Open Session

  1. Call to Order
     
  2. Roll Call
     

Action Items

  1. Consideration of applications submitted in response to Translational Projects Program Announcement (TRAN 1,2,3 or 4)
  1. Consideration of applications submitted in response to Clinical Trial Stage Projects Program Announcement (CLIN 1,2 or 3).

Closed Session

  1. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to agenda items 3 and 4 above. (Health & Safety Code 125290.30(f) (3) (B) and (C)).

Discussion Items

  1. Public comment
     
  2. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 510-340-9111 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at mbonneville@cirm.ca.gov or 510-340-9111.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.